BioMed X and Servier launch AI-powered antibody research at New XSeed Labs in Paris-Saclay
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
The company has confirmed that the deceased are 39
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
Subscribe To Our Newsletter & Stay Updated